Cargando…
EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
Autores principales: | Tfelt-Hansen, P, Kauffmann, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182244/ http://dx.doi.org/10.1186/1129-2377-15-S1-G37 |
Ejemplares similares
-
EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine
por: Pavbro, P, et al.
Publicado: (2014) -
Are the current IHS guidelines for migraine drug trials being followed?
por: Hougaard, Anders, et al.
Publicado: (2010) -
EHMTI-0368. Treatment of migraine attacks as suggested by Dr. John R. Graham in 1955. A historical analysis with current implications
por: Tfelt-Hansen, P, et al.
Publicado: (2014) -
EHMTI-0377. The influence of genetic constitution on migraine drug responses
por: Christensen, AF, et al.
Publicado: (2014) -
EHMTI-0021. The possible effect of telmisartan on the blood-brain barrier transport of verapamil
por: Saaby, PL, et al.
Publicado: (2014)